Johanna Vrielink

Papers

Total Citations

H-Index

About

Johanna Vrielink is a pioneering researcher in protein engineering and industrial biocatalysis, with a focus on evolving enzymes for pharmaceutical synthesis. Her most-cited work, "Altering the Substrate Specificity of Cephalosporin Acylase by Directed Evolution of the β-Subunit" (2002, 62 citations), addresses a critical bottleneck in antibiotic production. By applying directed evolution to the β-subunit of cephalosporin acylase, Vrielink and her team engineered an adipyl acylase capable of performing a one-step bioconversion of adipyl-7-ADCA to 7-ADCA—a key intermediate for semisynthetic cephalosporins. This breakthrough streamlined the synthesis of these vital antibiotics, replacing multi-step chemical processes with a cleaner, enzymatic route. Her work exemplifies how rational design and evolutionary pressure can reshape enzyme specificity for industrial applications. With 62 citations, this study remains a cornerstone in the field of directed evolution, influencing subsequent efforts to optimize biocatalysts for green chemistry. Vrielink’s contributions have advanced sustainable pharmaceutical manufacturing, earning her recognition among protein engineers and biotechnologists. Her research continues to inspire students and researchers exploring the frontiers of enzyme engineering for therapeutic compound production.